While platform players are going super-wide in their offering, some legal AI startups are going the other way and drilling ...

Royalty Pharma is less exposed to MFN drug pricing risks, offering downside protection in a volatile policy environment. See ...

CEO of the National Infusion Center Association argues against a drug price control policy known as “most favored nation.” ...

MFN proponents like to frame the policy as a way to stop “foreign freeloading.” But there's nothing tough or strategic about adopting the failed price-fixing systems of Europe or Canada.

India wants the U.S. to remove all tariffs—both MFN and country-specific—on high and medium-labour-intensive goods. These ...

FDA’s public guidance continues to warn that, “under most circumstances,” importing drugs for personal use is unlawful, ...

Worries about further hiccups in the potential trade deal and consequent higher tariffs between India and the United States ...

The MFN EO is designed to halt what the administration calls “global freeloading” — where other developed countries benefit from U.S.-funded drug innovation at significantly lower costs.

President Donald Trump issued an executive order reviving his controversial “Most Favored Nation” (MFN) drug pricing ...